高盐而非高蛋白摄入与常染色体显性多囊肾病进展加速相关
本研究基于589例ADPKD患者的观察性队列,通过24小时尿评估盐和蛋白摄入,血浆和肽素作为血管加压素替代指标。中位随访4.0年发现,盐摄入每增加1克/天,eGFR年变化为-0.11 mL/min/1.73m2,蛋白摄入无显著关联;盐对eGFR斜率的影响由血浆和肽素显著介导(粗分析77%,校正分析45%),而非收缩压。
要点
- 盐摄入每增加1克/天,eGFR年下降0.11 mL/min/1.73m2
- 蛋白摄入与eGFR年变化无显著关联
- 盐对eGFR斜率的影响主要由血浆和肽素介导,而非收缩压
核心结论
- 较高的盐摄入而非蛋白摄入可能与ADPKD疾病进展加速相关。
- 盐对eGFR斜率的影响主要由血浆和肽素介导,提示盐诱导的血管加压素升高是主要机制。
研究设计与样本
- 观察性队列研究,纳入589例ADPKD患者(59%女性),基线平均年龄47岁。
- 通过24小时尿样估算盐和蛋白摄入,并测量血浆和肽素作为血管加压素替代指标。
- 采用混合模型分析饮食摄入与eGFR年变化及身高调整总肾脏体积(htTKV)增长的关联。
主要发现
- 基线平均eGFR为64 mL/min/1.73m2,中位htTKV为880 mL。
- 平均估计盐摄入为9.1 g/天,蛋白摄入为84 g/天。
- 中位随访4.0年,eGFR中位评估6次,24小时尿中位收集5次。
- 盐摄入与eGFR年变化显著相关:每克盐为-0.11(95%CI 0.20至-0.02)mL/min/1.73m2。
- 蛋白摄入与eGFR年变化无显著关联:每克蛋白为-0.00001(95%CI -0.01至0.01)mL/min/1.73m2。
关键数值与推荐
- 盐摄入对eGFR斜率的影响由血浆和肽素显著介导:粗分析77%,校正分析45%。
- 该影响不由收缩压介导。
临床怎么用
- 在ADPKD患者管理中,可考虑限制盐摄入以延缓疾病进展。
- 蛋白摄入与疾病进展无显著关联,无需过度限制蛋白。
- 血浆和肽素可能作为监测盐摄入影响的生物标志物。
局限性
- 本研究为观察性队列,无法确立因果关系。
- 盐和蛋白摄入基于24小时尿估算,可能存在测量误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In autosomal dominant polycystic kidney disease (ADPKD), there are only scarce data on the effect of salt and protein intake on disease progression. Here we studied association of these dietary factors with the rate of disease progression in ADPKD and what the mediating factors are by analyzing an observational cohort of 589 patients with ADPKD. Salt and protein intake were estimated from 24-hour urine samples and the plasma copeptin concentration measured as a surrogate for vasopressin. The association of dietary intake with annual change in the estimated glomerular filtration rate (eGFR) and height adjusted total kidney volume (htTKV) growth was analyzed with mixed models. In case of significant associations, mediation analyses were performed to elucidate potential mechanisms. These patients (59% female) had a mean baseline age of 47, eGFR 64 mL/min/1.73m2 and the median htTKV was 880 mL. The mean estimated salt intake was 9.1 g/day and protein intake 84 g/day. During a median follow-up of 4.0 years, eGFR was assessed a median of six times and 24-hour urine was collected a median of five times. Salt intake was significantly associated with annual change in eGFR of -0.11 (95% confidence interval 0.20 - -0.02] mL/min/1.73m2) per gram of salt, whereas protein intake was not (-0.00001 [-0.01 - 0.01] mL/min/1.73m2) per gram of protein). The effect of salt intake on eGFR slope was significantly mediated by plasma copeptin (crude analysis: 77% mediation, and, adjusted analysis: 45% mediation), but not by systolic blood pressure. Thus, higher salt, but not higher protein intake may be detrimental in ADPKD. The substantial mediation by plasma copeptin suggests that this effect is primarily a consequence of a salt-induced rise in vasopressin.
引用
- Kramers BJ, Koorevaar IW, Drenth JPH, et al. Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease. Kidney Int. 2020. PMID: 32534051. doi:10.1016/j.kint.2020.04.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。